Figure S1 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial
Year: 2023
Type: other
Abstract: Supplemental Figure 1 (A) Progression-Free Survival in S0226 (B) Overall Survival in S0226
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361815261